Epirubicin Hydrochloride

Overview

Epirubicin HCl, a semisynthetic L-arabino derivative of doxorubicin, is an antineoplastic agent by inhibiting Topoisomerase. Epirubicin Hydrochloride is an anthracycline glycoside characterized by its bright red, crystalline powder form. As a derivative of doxorubicin, it intercalates DNA, disrupting topoisomerase II activity and inhibiting nucleic acid synthesis. Its amphipathic nature contributes to notable solubility in aqueous environments, supporting diverse in vitro applications. Frequently utilized in molecular biology and biochemical research, Epirubicin Hydrochloride enables investigation of DNA damage pathways, cell cycle regulation, and mechanisms of apoptosis.

Application

Products > Drug Discovery > Impurities > Anti-Neoplastic > Doxorubicin Hydrochloride and Impurities | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B0084-071755
• CAS No.: 56390-09-1
• Molecular Formula: C27H29NO11.HCl
• Molecular Weight: 579.98
• Purity: >98%
• Storage: Store at -20 °C, under inert atmosphere
• Solubility: Soluble in Methanol (Slightly, Heated), Water (Slightly)

Source

Original product source